Alembic Pharmaceuticals Ltd receives EIR for facility at Panelav

Alembic Pharmaceuticals Limited has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at our General Oral Solid Formulation Facility (F-I) at Panelav during the period from 9th March, 2020 to 13th March, 2020.

With this, EIR is in place for all our manufacturing facilities for international markets.

Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.908.3 as compared to the previous close of Rs. 917.85. The total number of shares traded during the day was 14712 in over 1441 trades.

The stock hit an intraday high of Rs. 924.6 and intraday low of 902. The net turnover during the day was Rs. 13445051.

Source : Equity Bulls

Keywords